|
|
|
pra_speakers.asp
Speakers Profiles
Timothy Barry, Ph.D.
National Center for Environmental Economics
US EPA
Washington, DC
Dr. Tim Barry is a senior analyst with the National Center for Environmental
Economics of the U.S. Environmental Protection Agency in Washington,
D.C. His research addresses quantitative uncertainty methods and
issues in support of environmental decision making, predominantly
for human
and ecological risk assessments. He holds a bachelor's degree in
chemistry and a doctorate in environmental acoustics/industrial
hygiene from
the Graduate School of Public Health at the University of Pittsburgh.
At EPA, he has been involved with the development and implementation
of key EPA policy and guidance documents for uncertainty and environmental
analysis including EPA's Policy for the Use of Probabilistic Analysis
in Risk Assessment (http://epa.gov/osa/spc/htm/probpol.htm) and EPA's
Guiding Principles for Monte Carlo Analysis (http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=29596).
His primary focus is on the development and implementation of quantitative
methods for the evaluation of uncertainty in risk assessments,
including Monte Carlo simulation analysis, Bayesian data analysis methods
including
the quantification and use of expert judgement. Working with the
Office of Water, he conducted EPA's first hierarchal (two dimensional)
Monte
Carlo analysis of cancer risks attributable to radon in drinking.
Dr. Barry worked closely with Superfund staff in developing their
guidance
on probabilistic risk assessment and supporting case studies. Current
key projects include a joint project with the Office of Pesticides
to develop and test their Tier II probabilistic models for avian
and aquatic exposures and risks related to pesticide usage, and
a review
of quantitative methods for estimating cancer risks from inhalation
exposures to asbestos at Superfund sites.
Donald A. Berry, Ph.D.
Chair, Department of Biostatistics and Applied Mathematics
MD Anderson Cancer Center
University of Texas
Dr. Donald A. Berry is an international expert in
the field of biostatistics. He holds the Frank T. McGraw Memorial Chair
for Cancer Research at
The University of Texas M. D. Anderson Cancer Center, where he is chairman
of the Department of Biostatistics and Applied Mathematics. His primary
interest is the prevention and treatment of breast cancer. He serves
as the faculty statistician on the Breast Cancer Committee of the Cancer
and Leukemia Group B (CALGB), a national oncology group. In this role
he designs and supervises the conduct and analysis of clinical trials
in breast cancer. A native of Massachusetts, Dr. Berry received his
Ph.D. in statistics from Yale University, and previously served on
the faculty at the University of Minnesota and at Duke University,
where he held the Edger Thompson Professorship in the College of Arts
and Sciences. The author of more than 200 published articles as well
as several books on biostatistics in medical research, Dr. Berry has
been the principal investigator for numerous medical research projects
funded by the National Institutes of Health and the National Science
Foundation. A current project funded by the National Cancer Institute
(CISNET: Cancer Intervention and Surveillance Network) is statistical
modeling to assess the relative contribution of screening mammography,
tamoxifen and chemotherapy to the drop in breast cancer mortality observed
in the United States since 1990. Another focus of Dr. Berry's statistical
research is designing clinical trials that utilize patients more efficiently
and that treat patients in the trials more effectively. Dr. Berry is
a statistics editor for the Journal of the National Cancer Institute
and associate editor for Breast Cancer Research and Treatment and also
for Clinical Cancer Research, and he is a Fellow of the American Statistical
Association and of the Institute of Mathematical Statistics.
Kenneth T. Bogen, Dr.PH.
Environmental Scientist
Energy and Environmental Directorate
Lawrence Livermore National Laboratory
University of California
Dr. Ken Bogen began his research at LLNL in 1986, where he has focused on applying
and improving methods to assess health risks posed by environmental chemicals
and radiation. As a PI, a Project Leader, or project co-investigator on research
projects funded by agencies including USDOE, USEPA, NIH/NCI, and CalEPA, his
research has involved regulatory toxicology, quantitative uncertainty analysis,
biologically based dose-response modeling, biodosimetric and pharmacokinetic
modeling, chem/rad exposure assessment, carcinogen risk assessment and modeling,
and accelerator mass spectrometry (AMS) assessment of exposures to chemical carcinogens
and 239Pu. He currently leads a 7-year clinic-based epidemiological study investigating
potential association of exposure to carcinogens formed in cooked meats with
increased prostate cancer risk in East Bay area African Americans, being conducted
in collaboration with UCSF and the Alta Bates Summit Medical Center in Oakland,
CA, with funding by the National Cancer Institute and the DOD Prostate Cancer
Research Program.
Dr. Bogen served during 1992-1994 on the National Academy of Sciences
National Research Council (NRC) committee (established by Congressional
request) that
issued the report Science and Judgment in Risk Assessment (1994)—the first
major NRC review of regulatory risk assessment since its pivotal 1983 report
Risk Assessment in the Federal Government: Managing the Process. More recently,
he served on the NRC Subcommittee on Assessing Toxicological Risks to Deployed
Military Personnel (2002-2004), which in March 2004 issued to the U.S Army the
report Review of the Army’s Technical Guides on Assessing and Managing
Chemical Hazards to Deployed Personnel, which recommends fundamentally new methods
for chemical risk characterization required to support risk trade-off decisions.
He chaired the U.S. Consumer Product Safety Commission’s Chronic Hazards
Advisory Panel on Diisononyl Phthalate (2000-2001). He has written/coauthored
numerous peer-reviewed papers, and one book, on risk assessment and related policy
issues. A member of the Society for Risk Analysis (SRA) since 1981, he served
in 1995 as President and in 1996 and 2004 as Councilor of SRA’s Northern
California Chapter, and has been a member (1995-present) and Trustee (2000)
of the SRA Dose-Response Specialty Group.
Dr. Bogen holds a Dr.PH. in environmental health sciences from the University
of California Berkeley School of Public Health, as well as degrees from Princeton
University (AB, Biol.), the George Washington University (MA, Science, Technology & Public
Policy), and the University of California Berkeley (MPH, environmental health
sciences).
Mark Burgman, Ph.D.
Professor
University of Melbourne
Dr. Mark Burgman is a Professor in Environmental Science in the School
of Botany at the University of Melbourne, Australia. He is an ecologist
known for his work on ecological modelling, conservation biology and
risk assessment. His work has included models to assist environmental
managers for a variety of species and ecological systems in a range
of settings including marine fisheries, forestry, vertebrate management
in national parks, electrical power utilities and mining. He worked
as a consultant ecologist and research scientist in Australia and the
United States before joining the University of Melbourne in 1990. In
Australia, he acts on scientific advisory panels for the Victorian
EPA, the Zoological Board and the Australian Antarctic Division. He
was recently appointed to the Australian Biological Diversity Ministerial
Advisory Committee.
Dr. Burman received a BSc in biology from the University of New South
Wales in 1977 and a PhD in ecology from the State University of New
York at Stony Brook in 1987. He has authored four books, edited two
others, and has contributed over 100 articles to refereed books and
scientific journals. His most recent book 'Risks and decisions for
conservation and environmental management' appeared through Cambridge
in 2005.
Gregory Campbell, Ph.D.
Division of Biostatistics
Center for Devices and Radiological Health
US Food and Drug Administration
Dr. Gregory Campbell is the Director of the Division of Biostatistics
in the Office of Surveillance and Biometrics (OSB) of FDA’s Center
for Devices and Radiological Health (CDRH). He is also in the Senior
Biomedical Research Service (SBRS) in the Department of Health and
Human Services. He leads a group of over 40 statisticians that provides
statistical support to CDRH as a whole and, in particular, the statistical
reviews of FDA’s pre-market device submissions. He is a Fellow
of the American Statistical Association. His current research interests
include non-inferiority studies, the use of causal inference and propensity
scores for studies with historical controls, the evaluation of microarrays
and proteomic platforms, and the development of Receiver Operating
Characteristic methodology for the evaluation of diagnostic tests in
the trade-off of sensitivity and specificity.
Dr. Campbell received his B.S. in Mathematics from the University of
Dayton, M.S. in Mathematics from Michigan State University and an M.S.
and Ph.D. in Mathematical Statistics from Florida State University.
His doctoral thesis concerned the use of Bayesian nonparametric statistics
in estimation and ranking problems.
After his Ph.D., he joined the faculty in the Department of Statistics
at Purdue University where he developed new statistical methodology
for optimal stopping and for bivariate survival estimation. Then, he
went to the National Institutes of Health where he became a tenured
intramural research scientist, Acting Chief of the Laboratory of Statistical
and Mathematical Methodology in the Division of Computer Research and
Technology and then the Chief of the Analytical Biometrics Section
in the National Institute of Neurological Disorders and Stroke (NINDS).
In these positions he developed new statistical methodology and collaborated
with medical researchers. In NINDS he led a group in the statistical
analysis of neuroimaging. Since coming to the FDA, he planned a Bayesian
workshop for medical device companies in 1998 and was a co-planner
and speaker for the May, 2004, workshop jointly sponsored by FDA and
Johns Hopkins University “Can Bayesian Approaches to Studying
New Treatments Improve Regulatory Decision Making?” He has led
a very successful effort for the past seven years to work with medical
device companies to plan, conduct and analyze Bayesian clinical trials
for regulatory submission. He served as co-chair in 2000 of the FDA/Industry
Workshop jointly sponsored by the FDA Statistical Association and the
Biopharmaceutical Section of the American Statistical Association.
He has been the author or co-author of over 90 scientific publications.
Rory B. Conolly, Sc.D.
Senior Research Biologist
National Center for Computational Toxicology
Office of Research and Development
U.S. Environmental Protection Agency
Dr. Rory Conolly is a Senior Research Biologist in the U.S EPA’s
National Center for Computational Toxicology in Research Triangle Park,
North Carolina. His main research interest is in the use of computational
systems biology to understand the dose response behaviors of environmental
stressors, including chemicals and ionizing radiation. Dr. Conolly received
formal training in biology and biochemical toxicology and became interested
in physiologically based pharmacokinetic models in the early 1980's.
Initially, he studied the biochemical mechanism of hepatic DNA damage
by 1,2-dichloroethanoe and the ototoxicity of toluene. He has developed
simulation models and directed laboratory studies for a variety of chemicals,
including organophosphates and halogenated hydrocarbons, worked on stochastic
simulation models to examine the roles of cellular division and apoptosis
in chemical carcinogenesis, and on several physiologically based pharmacokinetic
models, including models describing pregnancy and lactation. More recently,
he played a central role in the development of a biologically-motivated
cancer risk assessment for formaldehyde that used advanced dosimetry
and tissue response modeling. His current research interests focus on
how basic biochemical regulatory networks, including the MAPK signal
transduction pathway and the relationship between DNA damage, cell cycle
checkpoint controls and apoptosis, influence dose-response behaviors.
Dr. Conolly received the U.S. Society of Toxicology’s (SOT) Lehman
Award for lifetime achievement in risk assessment in 2005. He was a member
of the National Academy of Sciences Board on Environmental Studies and
Toxicology from 2004 until joining the EPA in 2005, President of the
SOT Biological Modeling Specialty Section (2000 – 2001), President
of the SOT Risk Assessment Specialty Section (1997 1998) and a member
of the SOT Risk Assessment Task Force (1998 - 2000). He is an Adjunct
Professor of Biomathematics at North Carolina State University, a Faculty
Affiliate, Department of Environmental and Radiological Health Sciences,
Colorado State University and has four times received awards from the
SOT Risk Assessment Specialty Section (1991, 1999, 2003, 2004) for presentations
and publications in risk assessment. Dr. Conolly maintains an active
interest in teaching, having most recently given a 3-day course on simulation
modeling and risk assessment in Germany and lectures on risk assessment
at North Carolina State University. In addition to the SOT, he is a member
of the Society for Risk Analysis and the American Association for the
Advancement of Science. He has been a diplomate of the American Board
of Toxicology since 1980.
Dr. Conolly was born in London, England and raised in Canada and the
United States. He received a bachelor's degree in biology from Harvard
College in 1972, a doctorate in physiology/toxicology from the Harvard
School of Public Health in 1978, and spent a post-doctoral year at the
Central Toxicology Laboratory of Imperial Chemical Industries, PLC, Cheshire,
England. He was a member of the Toxicology Faculty at The University
of Michigan School of Public Health from 1979 through 1986, and worked
with the U.S. Air Force Toxic Hazards Research Division, Wright-Patterson
Air Force Base, Ohio from 1986 until 1989. In 1989 Dr. Conolly joined
the Chemical Industry Institute of Toxicology (CIIT, later called the
CIIT Centers for Health Research). He worked at CIIT until 2005, when
he joined the U.S. EPA.
Alison C. Cullen, Ph.D.
Associate Professor
Evans School of Public Affairs
University of Washington
Dr. Alison Cullen has served on the faculty of the
Evans School of Public Affairs at University of Washington since 1995.
Previously,
she held positions in the Water Quality Branch of the U.S. Environmental
Protection Agency and on the faculty of the Harvard University School
of Public Health. Her research involves the analysis of environmental
risks, decision making in the face of risks which are uncertain or
varied across populations, and the application of value of information
and distributional techniques. She is active in environmental exposure
assessment projects in the US and internationally. Dr. Cullen also
has served as a technical consultant to the Natural Resources Defense
Council, the Environmental Defense Fund, the National Center for Atmospheric
Research and for the National Academy of Science.
Scott Farrow, Ph.D.
Government Accounting Office
Washington DC
Dr. Scott Farrow is the Chief Economist of the US Government Accountability
Office. He advises the Comptroller General and the senior managers
of the GAO on the design and implementation of economic analyses at
the request of Congress. In the Fall of 2005, Dr. Farrow will be assuming
post of Chairman, Department of Economics at the University of Maryland
- Baltimore County.
Formerly, Dr. Farrow was the Director of the Center for the Study and
Improvement of Regulation at Carnegie Mellon University. Since receiving
his Ph.D. in economics from Washington State University in 1983, Dr.
Farrow has served as a member of the faculty at Carnegie Mellon University
and the Pennsylvania State University, served in the Executive Office
of the President, the Department of the Interior, and carried out domestic
and international consulting work for Dames & Moore, Inc.
Dr. Farrow has recently co-authored software (FERET) to assist in risk
and cost-benefit analysis of air pollution and co-edited Improving
Regulation with Paul Fischbeck. Other publications include journal
articles, primarily on natural resource and environmental policy, and
a book on federal management of energy resources from the Outer Continental
Shelf. Current research concerns the use of new approaches for Government
investment when uncertainty and irreversibility exist, improving measures
of the economic performance of Government programs including Homeland
Security, and an analytical approach to the precautionary principle.
Dr. Farrow is listed in Who’s Who in America and similar publications.
Adam M. Finkel, Ph.D.
University of Medicine and Dentistry of New Jersey (UMDNJ) School of
Public Health
and Visiting Professor
Woodrow Wilson School of Public and International Affairs
Princeton University
Dr. Adam M. Finkel is one of the nation’s leading experts in
the evolving field of risk assessment and cost-benefit analysis, with
20 years of experience in both the scientific and public policy aspects
of environmental and occupational health. He is currently Professor
of Environmental and Occupational Health at the University of Medicine
and Dentistry of New Jersey (UMDNJ) School of Public Health, and Visiting
Professor at the Woodrow Wilson School of Public and International
Affairs at Princeton University. From 2000 to 2003, Dr. Finkel was
Regional Administrator for the U.S. Occupational Safety and Health
Administration (OSHA) in Denver, Colorado, responsible for regulatory
enforcement, compliance assistance, and outreach activities in CO,
MT, ND, SD, UT, and WY. From 1995 to 2000, he was Director of Health
Standards Programs at OSHA headquarters, and was responsible for promulgating
and evaluating regulations to protect the nation’s workers from
chemical, radiological, and biological hazards. At OSHA, Dr. Finkel
also negotiated several national “regulatory partnerships” bringing
manufacturers, customers, and unions together to provide worker protections
beyond what could have been achieved by command-and-control regulation.
From 1987 to 1994, Dr. Finkel was a fellow at the Center for Risk Management
(CRM) at Resources for the Future, where he pioneered new methods for
comparing uncertain and purportedly “incommensurable” risks,
for making risk estimates relevant to individuals with various degrees
of susceptibility, and for estimating the monetary value of research
designed to reduce specific uncertainties. During this time, he also
served as director of CRM’s Rational Risk Reduction Program,
a series of research and outreach activities examining the strengths
and limitations of risk assessment for setting national environmental
priorities. In early 1995, he was a senior fellow at the Cecil and
Ida Green Center for the Study of Science and Society at the University
of Texas at Dallas. His primary research interests are: (1) quantifying
and communicating the uncertainties in risk estimates, and critically
examining the claim that risk estimates are invariably too “conservative”;
(2) accounting for variations in human susceptibility to environmental
and occupational disease; and (3) evaluating policies and technologies
that show promise for reducing environmental and occupational exposures
simultaneously, rather than transferring risks from one population
to the other. Dr. Finkel has published more than 35 articles on risk
assessment and management in the scientific, legal, and popular literature,
and was co-editor of the book Worst Things First? The Debate over Risk-Based
National Environmental Priorities (Johns Hopkins Univ. Press, 1994).
Previously, he was editor-in-chief of the weekly newsletter “Hazardous
Materials Intelligence Report” and an advisor to “Universo
Veintiuno,” a research group in Mexico City studying hazardous
waste and air pollution problems. From 1991-1994 he was a member of
the National Academy of Sciences Committee on Risk Assessment for Hazardous
Air Pollutants, and authored a major portion of the committee’s
study Science and Judgment in Risk Assessment. He was President of
the Risk Assessment and Policy Association from 1999 to 2001, and recently
received the Chauncey Starr Award from the Society for Risk Analysis
(outstanding contributions to the field by an analyst under 40). He
was recently named editor-in-chief of the journal RISK: Health, Safety & Environment.
Dr. Finkel holds an Sc.D. in environmental health sciences from the Harvard School
of Public Health, a master’s degree in public policy from Harvard’s
John F. Kennedy School of Government, an A.B. in biology from Harvard College,
and is a Certified Industrial Hygienist. He lives in Pennington, New Jersey,
with his wife Joanne (a clinical psychologist) and 5-year-old daughter Maia;
he is also a professional singer and choral conductor.
H. Christopher Frey, Ph.D.
Professor
Department of Civil, Construction and Environmental Engineering
North Carolina State University
Dr. H. Christopher Frey is a professor in the Department of
Civil, Construction, and Environmental Engineering at North Carolina
State University (NCSU).
Dr. Frey’s research program is in areas pertaining to air pollution,
risk assessment, energy systems, and related topics. Examples of current
and recent research activities include: (a) development and application
of methods for quantification of variability and uncertainty in environmental
models; (b) identification and evaluation of methods for sensitivity
analysis applicable to risk assessment models; (c) measurement and modeling
of real world in-use tailpipe emissions of vehicles and equipment, including
onroad and nonroad; (d) probabilistic emissions inventories; and (e)
modeling and assessment of advanced energy conversion systems, such as
gasification, at the level of a process flowsheet, as well as broader
quantification of life cycle inventories. The major sponsors of Dr. Frey’s
research include the National Science Foundation, U.S. Environmental
Protection Agency, U.S. Department of Energy, U.S. Department of Agriculture,
NC Department of Transportation, and others.
Dr. Frey is one of seven appointed members of the Scientific Advisory
Panel of the U.S. Environmental Protection Agency under the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA). He is currently a member of the
National Research Council (NRC) Committee on the Effects of Changes in
New Source Review Programs for Stationary Sources of Air Pollutants.
He is a lead author for the Intergovernmental Panel on Climate Change
(IPCC) cross-cutting good practice guidance chapter on uncertainty in
greenhouse gas emission inventories. He was a contributing author on
uncertainty and sensitivity analysis sections of the Food and Agriculture
Organization (FAO) and World Heath Organization (WHO) draft guidance
on microbial risk characterization, and currently serves on a WHO working
group pertaining to probabilistic exposure assessment. He is the lead
author for the chapter on uncertainty and sensitivity analysis for the
tri-lateral (U.S., Canada, Mexico) NARSTO emission inventory assessment
document.
Dr. Frey is the current President-Elect of the Society for Risk Analysis.
He is a past president of the RTP chapter of SRA and served for three
years on the SRA Council. Dr. Frey’s education includes a B.S.
in Mechanical Engineering from the University of Virginia, a Master of
Engineering in Mechanical Engineering from Carnegie Mellon, and a Ph.D.
in Engineering and Public Policy at Carnegie Mellon.
Andrew Hart, Ph.D.
Central Science Laboratory (CSL)
Department of Environment, Food and Rural Affairs
Sand Hutton
York, United Kingdom
Dr. Andy Hart is employed at the Central Science Laboratory (CSL),
York, UK, a research agency of the UK Department for Environment, Food
and Rural Affairs. He leads CSL’s Risk Analysis Team and coordinates
the application of quantitative risk assessment methods throughout
all areas of CSL science including food, agriculture and environment.
Dr Hart has a BSc in Environmental Biology and a DPhil in Behavioural
Ecology, and first joined the UK agriculture ministry in 1982 to research
the effects of pesticides on birds. He expanded his field of work first
to other types of pesticide effects and then to the use of quantitative/probabilistic
methods of risk assessment. His team is currently applying probabilistic
methods to human exposure to food contaminants including dioxins and
chemical migrants from packaging, to the ecological risks of pesticides,
and to problems involving invasive species and GM crops. Dr Hart has
over 30 peer-reviewed journal publications and has edited a book “Avian
Effects Assessment: A framework for contaminant studies” (SETAC
Press, 2001). He is a Member of the European Food Safety Authority
(EFSA) Scientific Panel on plant health, plant protection products
and their residues; a Member of the EFSA Scientific Committee Working
Group on Exposure Assessment; an Editorial Board Member for the journal ‘Human
and Ecological Risk Assessment’; Coordinator of EUFRAM, a collaborative
project with 29 partners developing a European Framework for probabilistic
assessment of environmental impacts of pesticides (www.eufram.com);
Coordinator of RA-RM, European Workshop on the Interface between Risk
Assessment and Risk Management (see www.ra-rm.com); and has served
on the US EPA’s FIFRA Science Advisory Panel.
Dale Hattis, Ph.D.
George Perkins Marsh Institute
Clark University
Dr. Dale Hattis is Research Professor with the George Perkins Marsh
Institute at Clark University. For the past thirty years he has been
engaged in the development and application of methodology to assess
the health, ecological, and economic impacts of regulatory actions.
His work has focused on the development of methodology to incorporate
interindividual variability data and quantitative mechanistic information
into risk assessments for both cancer and non-cancer endpoints. Specific
studies have included quantitative risk assessments for hearing disability
in relation to noise exposure, reproductive effects of ethoxyethanol,
neurological effects of methyl mercury and acrylamide, and chronic
lung function impairment from coal dust, four pharmacokinetic-based
risk assessments for carcinogens (for perchloroethylene, ethylene oxide,
butadiene, and diesel particulates), an analysis of uncertainties in
pharmacokinetic modeling for perchloroethylene and an analysis of differences
among species in processes related to carcinogenesis. Recent research
has also explored age-related differences in sensitivity to carcinogensis
and other effects. Major current research projects include PBPK modeling
of acrylamide dose in rats and humans, and mechanism-based dose response
modeling of carcinogenic effects from ionizing radiation. He is a leader
in efforts to replace the current system of uncertainty factors with
distributions based on empirical observations. He is a member of the
Environmental Health Committee of the EPA Science Advisory Board, and
for several years he has served as a member of the Food Quality Protection
Act Science Review Board. He has also served as a member of the National
Research Council Committee on Estimating the Health-Risk-Reduction
Benefits of Proposed Air Pollution Regulations. He has been a councilor
and is a Fellow of the Society for Risk Analysis, and serves on the
editorial board of its journal, Risk Analysis. He holds a Ph.D. in
Genetics from Stanford University and a B.A. in biochemistry from the
University of California at Berkeley.
Igor Linkov, Ph.D.
Senior Scientist
Cambridge Environmental, Inc.
Dr. Igor Linkov is a Senior Scientist with Cambridge Environmental
Inc. in Cambridge, MA, and an Adjunct Professor of Engineering and
Public Policy at Carnegie Mellon University in Pittsburgh, PA. Prior
to joining Cambridge Environmental, Dr. Linkov was a Senior Risk Assessor
and Team Leader at ICF Consulting and Arthur D. Little, Inc. He has
performed state-of-the-art ecological risk assessments, including probabilistic
risk assessments, environmental decision-making analyses, and spatially-explicit
environmental threat investigations both in the United States and abroad
in support of government and commercial clients. Dr. Linkov has conducted
probabilistic risk assessments for several Superfund sites, including
the Hudson River site. He was one of the technical leaders developing
the FISHRAND model, one of the first applications in which EPA used
a combination of Bayesian and probabilistic risk assessment methods
for assessing site risks. Dr. Linkov’s current interests include
bringing together tools and methodologies developed in the fields of
operations research and risk assessment to address emerging threats.
For the US Army, EPA, NATO, Navy, and NOAA, he organized two workshop
that developed multi-criteria decision analysis frameworks and tools
for environmental management. Results of this work are being widely
used within the Army Corps of Engineers. He has contributed in developing
methods for using Habitat Suitability Index (HSI) models to modify
exposure estimates in ecological risk assessments, which is currently
being balloted to become an ASTM Standard. In addition, Dr. Linkov
has developed his innovative methods into user-friendly software tools.
For example, he is at present implementing a generic GIS module that
will add capacity for analysis and visualization of spatially distributed
data for the Army Risk Assessment Modeling System (ARAMS). For the
American Chemistry Council (ACC) and US Army, he is developing the
Risk-Trace model for spatially explicit ecological risk assessment.
He is also developing the Questions and Decision (QnD) model which
will utilize multi-criteria decision analysis methods and tools for
environmental management by the US Army Corps of Engineers. Many of
these projects and tools draw upon advanced statistical methods, including
Bayesian analysis, probabilistic modeling, and geostatistical modeling.
Dr. Linkov is active in organizing workshops and conferences. For the
Society for Risk Analysis (SRA) and the Interstate Technology & Regulatory
Council, he organized a training workshop on Probabilistic Risk Assessment
in March 2005. The SRA workshop complements the current SOT conference
by adding a practical application side through involvement of state
and local regulators and documenting PRA application case studies.
He is currently organizing a workshop on “Risk Management Tools
for Environmental Security, Critical Infrastructure and Sustainability” (Venice,
2006) and on “Environmental Multi-Criteria Decision Analysis
(e-MCDA) for Analytic-Deliberative Decision Making” (Washington,
2006). In 2004-2005, he organized workshops on “The Role of Risk
Assessment in Addressing Environmental Security Needs” as well
as “Environmental Security in Harbors and Coastal Areas,” supported
by NATO and the US Army Corps of Engineers. As a Member of the Organizing
Committee for the 2003, 2004, and 2005 annual meetings of the Society
for Risk Analysis, Dr. Linkov was responsible for the ecological risk
assessment and homeland security tracks. He has published widely on
environmental policy, environmental modeling, and risk analysis, including
six books and over 70 peer-reviewed papers and book chapters. Dr. Linkov
serves as a Scientific Advisor to the Toxic Use Reduction Institute,
a position that requires nomination by the Governor of Massachusetts.
Dr. Linkov is President for the Society for Risk Analysis-New England.
He is the Founding Chair of the SRA Decision Analysis and Risk Specialty
Group. He is also Past Chair of the SRA Ecological Risk Assessment
Specialty Group and participates in several SRA and SETAC (Society
of Environmental Toxicology and Chemistry) Committees. Dr. Linkov has
served on many review and advisory panels for the US and international
agencies.
Dr. Linkov has a BS and MSc in Physics and Mathematics (Polytechnic
Institute, Russia) and a Ph.D. in Environmental, Occupational and Radiation
Health (University of Pittsburgh). He completed all course requirements
for MS in Engineering and Public Policy at Carnegie Mellon University
and had his postdoctoral training in Biostatistics, Toxicology and
Risk Assessment at Harvard University.
Dwayne Moore, Ph.D.
Cantox Environmental
Ottawa, Ontario
Canada
Dr. Dwayne Moore has a B.Sc. in Biology from the University of Western
Ontario, and a M.Sc. and Ph.D. in wetland community ecology from the
University of Ottawa. After graduating, he worked for six years at
Environment Canada, the first two years developing environmental quality
guidelines for industrial chemicals, and the last four years conducting
ecological risk assessments for priority substances in Canada. He was
with the Cadmus Group for nearly eight years (April 1996 to December
2003), first as a Senior Associate and then as a Principal. Dr. Moore
recently joined Cantox Environmental as a Vice President and Senior
Scientist.
Dr. Moore has considerable expertise in ecological risk assessment,
the development of environmental quality guidelines and criteria, community
ecology, multivariate statistics, uncertainty analysis, and analysis
of toxicity data. He is currently leading the ecological risk assessment
for the PCBs-contaminated Housatonic River in Massachusetts on behalf
of the U.S. EPA, and recently co-led the ecological risk assessment
of the Calcasieu Estuary in Louisiana also on behalf of the U.S. EPA.
Dr. Moore has conducted numerous reviews of site-specific assessments
including those for the PCBs-contaminated Hudson River on behalf of
the U.S. EPA, potential spills of Orimulsion and Fuel Oil #6 in Tampa
Bay on behalf of the U.S. EPA, and the Darlington nuclear facility
on behalf of Ontario Power Corporation.
Dr. Moore has led projects
to assess the ecological risks of a variety of chemicals including
hexachlorobenzene, chloroform, chlorinated wastewater effluents,
waste crankcase oils, mercury, PCBs, and hexachlorobutadiene. Dr. Moore
has
also been involved in the Environment Canada probabilistic risk assessments
of ammonia and chloramines. He led the effort to update and considerably
expand Environment Canada’s guidelines for the conduct of ecological
risk assessments of priority substances under the Canadian Environmental
Protection Act. Dr. Moore authored the chapter on probabilistic risk
assessment in Ecological Risk Assessment and Prioritization Process
for the Department of Energy (DOE). The chapter includes state-of-the-art
statistical and modeling techniques for use in higher tier assessments
including: first and second order Monte Carlo analysis, variance
propagation, probability bounds analysis, interval analysis and cost-benefits
analysis.
To illustrate these and other techniques, Dr. Moore prepared a case
study that estimated the effects of methylmercury and PCBs to mink
and kingfishers at a CERCLA/RCRA site near Oak Ridge, Tennessee and
compared these effects to the costs and benefits of several remediation
alternatives.
Dr. Moore has been involved in projects to prepare
guidance, training, and case studies for probabilistic risk assessments
for several
agencies including the ACC, CEFIC, pesticide companies, and the U.S.
EPA Office of Pesticide Products. He recently completed a detailed
evaluation of a large spatially-explicit population model (PATCH)
for the U.S. EPA Office of Research and Development, and led the
development
of ambient water quality criteria for mercury for the Water Environment
Research Foundation. Dr. Moore has conducted numerous analyses of
toxicity data sets using regression-based approaches. For the Water
Environment
Research Federation, he conducted regression analyses of hundreds
of data sets to determine intra- and inter-laboratory variability
for
different types of bioassays. Dr. Moore co-chaired the Society of
Environmental Toxicology and Chemistry (SETAC) Pellston conference
on the use of
uncertainty analysis in ecological risk assessment and co-edited
the book that followed from the conference. He is currently serving
on
the SETAC Pellston steering committee for Probabilistic Risk Assessments
of Pesticides, and has served on a past steering committee to develop
an ecological risk assessment decision support system. Dr. Moore
has participated in several other Pellston workshops (e.g., assessing
multiple
stressors, re-evaluation of environmental quality criteria), and
has participated in EPA Science Advisory Panels and other EPA peer
review
workshops. Dr. Moore has been a member of the editorial board for
Human and Ecological Risk Assessment journal since its inception
and was
a member of the editorial board for Environmental Toxicology and
Chemistry from 1999 to 2003.
M. Granger Morgan, Ph.D.
Department of Engineering and Public Policy
Carnegie Mellon University
Dr. M. Granger Morgan is Professor and Head of the Department of Engineering
and Public Policy at Carnegie Mellon University where he is also University
and Lord Chair Professor in Engineering. He is also a Professor in
the Department of Electrical and Computer Engineering and in The H.
John Heinz III School of Public Policy and Management. Morgan's research
addresses problem in science, technology and public policy. Much of
it has involved the development and demonstration of methods to characterize
and treat uncertainty in quantitative policy analysis. He works on
risk analysis, management and communication; on problems in the integrated
assessment of global change; on improving health, safety, and environmental
regulation; on energy systems, focused particularly on electric power;
and on several other topics in technology and public policy. His books,
published by Cambridge University Press, on Uncertainty: A guide to
dealing with uncertainty in quantitative risk and policy analysis (1990
with Max Henrion) and Risk Communication: A mental models approach
(2002 with Baruch Fischhoff, Ann Bostrom, and Cynthia J. Atman) are
widely cited as providing the definitive treatment of these topics.
At Carnegie Mellon, Morgan directs the new NSF Center on Climate Decision
Making and co-directs, with Lester Lave, the Carnegie Mellon Electricity
Industry Center. Morgan serves as Chair of the EPA Science Advisory
Board, Chair of the EPRI Advisory Council, and Chair of the Scientific
and Technical Council for the International Risk Governance Council
(based in Geneva, Switzerland). He is a Fellow of the AAAS, the IEEE,
and the Society for Risk Analysis.
Dr. Morgan holds a BA from Harvard College (1963) where he concentrated
in Physics, an MS in Astronomy and Space Science from Cornell (1965)
and a Ph.D. from the Department of Applied Physics and Information
Sciences at the University of California at San Diego (1969).
D. Warner North, Ph.D.
Northworks, Inc.
Belmont, CA
Dr. D. Warner North is president and principal scientist of Northworks, Inc.,
a consulting firm in Belmont, California, and a consulting professor in the Department
of Management Sciences and Engineering at Stanford University. He previously
served as the Assistant Director for Decision Analysis at the Stanford Research
Institute. Over the past thirty years, Dr. North has carried out applications
of decision analysis and risk analysis for electric utilities in the United States
and Mexico, for the petroleum and chemical industries, and for governmental agencies
with responsibility for energy and environmental protection.
Dr. North has served as a member and consultant to the Science Advisory Board
of the US Environmental Protection Agency since 1978. He was appointed by the
President to serve as a member of the US Nuclear Waste Technical Review Board
in 1989-1994. Dr. North is co-author of many reports dealing with environmental
risk for the National Academy of Sciences, including “Risk Assessment in
the Federal Government: Managing the Process (1983)”, “Improving
Risk Communication (1989)”, “Science and Judgment in Risk Assessment
(1994)”, and “Understanding Risk: Informing Decisions in a Democratic
Society (1996)”. Dr. North was a member of the Board on Radioactive Waste
Management of the National Research Council from 1995 until 1999. He was the
chair for the steering and advisory committees for the International Workshop
on the Disposition of High-Level Radioactive Waste held in 1999 which led to
the report “Disposition of High-Level Waste and Spent Nuclear Fuel: The
Continuing Societal and Technical Challenge” published in June 2001.
Dr. North is past president (1991-92) of the International Society for Risk Analysis,
a recipient of the Frank P. Ramsey Medal from the Decision Analysis Society in
1997 for lifetime contributions to the field of decision analysis, and the 1999
recipient of the Outstanding Risk Practitioner Award from the Society for Risk
Analysis. He also received National Science Foundation Fellowships in physics
and mathematics while at Stanford.
Dr. North has given invited presentations, lectures, and testimony for a variety
of professional societies, conferences, academic audiences, public utility commissions,
Congressional committees and other legislative bodies. He has given numerous
seminars in decision analysis, risk assessment, capital expenditure analysis,
and related subjects for executives in the US, Europe and Latin America. Dr.
North serves on the editorial boards of Risk Analysis and is a member of Sigma
Xi.
Dr. North received his Ph.D. in operations research from Stanford University,
an MS in Physics and another in MS in Mathematics also from Stanford University,
and his B.S. in physics from Yale University.
Paul Scott Price, M.S.
Director
The LifeLine Group, Inc.
Mr. Paul Price is a modeler and researcher on chemical exposures and
other sources of risk. He is a director of The Lifeline Group Inc.
a non profit company that develops and makes publicly available software
for the assessment of exposure and risk. Mr. Price has more than 25
years of experience in assessing exposure to chemicals for industry,
government, and trade associations. He has authored over 20 articles
and book chapters on exposure and risk assessment. Areas of interest
include integration of exposure and PBPK models, Monte Carlo modeling
of uncertainty and variability in exposure and risk, dose reconstruction,
aggregate and cumulative risk, worker exposures, and consumer products
and pesticide exposures. Mr. Price has served on advisory boards for
EPA, The State of California, the Army Corp of Engineers, the Department
of Defense, and industry.
Lorenz Rhomberg, Ph.D.
Principal
Gradient Corporation
Cambridge, MA
Dr. Lorenz Rhomberg is an expert in quantitative risk
assessment, including dose-response analysis, pharmacokinetic modeling,
and probabilistic methods, with special experience
in chlorinated solvents and endocrine-active agents. He is the author of books
and more than 50 articles on these topics. Before joining Gradient, Dr. Rhomberg
was on the faculty of the Harvard School of Public Health, and at the U.S. EPA.
Dr. Rhomberg is active in professional groups and environmental policy development,
focusing on current issues in the interpretation of toxicological data in human
health risk assessment through service on panels sponsored by government, industry,
and such organizations as the National Academy of Sciences and the International
Life Sciences Institute. He has participated in several recent FIFRA Scientific
Advisory Panel meetings concerning cumulative risk. Dr. Rhomberg holds a Ph.D.
in population biology from State University of New York at Stony Brook.
Glenn W. Suter, II, Ph.D.
Science Advisor
National Center for Environmental Assessment
US Environmental Protection Agency
Dr. Glenn Suter is a Science Advisor in the U.S. Environmental Protection
Agency’s National Center for Environmental Assessment-Cincinnati,
and was formerly a Senior Research Staff Member in the Environmental
Sciences Division, Oak Ridge National Laboratory, U.S.A. He has a Ph.D.
in Ecology from the University of California, Davis, and 28 years of
professional experience including 23 years of experience in ecological
risk assessment. Dr. Suter is the principal author of two texts in
the field of ecological risk assessment, editor of two other books
and author of more than a hundred open literature publications. He
is Associate Editor for Ecological Risk of “Human and Ecological
Risk Assessment,” and Reviews Editor for the Society for Environmental
Toxicology and Chemistry (SETAC). Dr. Suter has served on the International
Institute of Applied Systems Analysis Task Force on Risk and Policy
Analysis, the Board of Directors of SETAC, an Expert Panel for the
Council on Environmental Quality, and the editorial boards of “Environmental
Toxicology and Chemistry,” “Environmental Health Perspectives,” and “Ecological
Indicators.” Dr. Suter is the recipient of numerous awards and
honors; most notably, he is an Elected Fellow of the American Association
for the Advancement of Science and he received SETAC’s Global
Founder’s Award, their highest award for career achievement.
His research experience includes development and application of methods
for ecological risk assessment and ecological epidemiology, development
of soil microcosm and fish toxicity tests, and environmental monitoring.
His work is currently focused on the development of methods for determining
the causes of biological impairments and on providing guidance for
the Agency on endpoints for ecological risk assessment.
|
